Cefdinir
Product Images NDC 67296-0765

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cefdinir (NDC 67296-0765). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

67296-0765 (Doc20161117143631 001)

This is a description of two medication products with the same active ingredient Cefdinir, one containing 20 capsules and has NDC code 67296-0765-1, and the other containing 14 capsules with NDC code 67296-0765-2. Both are manufactured by Sandoz GmbH in Austria and distributed by Redpharm Drug based in Eden Prairie, MN. The capsules are prescription-only and the recommended dosage for adults can be found in the package insert. Lot numbers and expiration dates are also provided, and they should be kept at a controlled room temperature of 20-25 C (68-77 F). The rest of the text is not relevant to the medication description.*

FDA Label Image

Cefdinir (Doc20180418091013 001)

CEFDINIR is a medication available in capsule form with 300MG strength. The recommended adult dose and other important information can be found in the package insert. Lot number, expiry date, and other manufacturing details are provided on the label. The medication should be stored at controlled temperature in a cool and dry place. The distributor of the medication is Redpharm Drug, located in Eden Prairie.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.